Evaluation of Respiratory Function During Self-induced Cognitive Trance (SPIROTRANSE)

Centre Hospitalier Metropole Savoie

Status: Completed

Conditions: Respiratory Function

Treatments: Diagnostic Test: spirometry

Study type: Interventional

Funder types: Other

Identifiers

NCT06121960

CHMS22009

Details and patient eligibility

About

The goal of this Prospective, monocentric, non-randomized, open-label study aimed at evaluating the variation of FEV1 during a state of self-induced cognitive trance participant population: Person with expertise in the practice of TCAI can be inclued. (at least 6 months, in order to be able to control the depth of the trance and to have a motor control allowing the realization of a spirometry)

The main question:

Study the significant variation of FEV1 before, during, or after the state of self-induced cognitive trance

Full description

Primary objective : Study the significant variation of FEV1 before, during, or after the state of self-induced cognitive trance judgment criteria:

Significant variations in:

PEF PEF25 PEF50 PEF75 FVC Inspiratory capacity, SpO2 Respiratory rate before, during, or after the self-induced cognitive trance state Evolution of the feeling of self-efficacy, assessed by questionnaire

Enrollment: 9 patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Person over 18 years old
• Person with expertise in the practice of TCAI. (at least 6 months, in order to be able to control the depth of the trance and to have a motor control allowing the realization of a spirometry)
• Person affiliated with social security or beneficiary of such a scheme.
• Person having given, in writing, their free and informed consent to participate in the study

Exclusion criteria

• Person deprived of liberty by judicial or administrative decision, person subject to a measure of legal protection.
• Exclusion period for other studies
• Person likely, according to the investigator's assessment, not to be cooperative or respectful of the obligations inherent in participation in the study
• Person with a psychiatric, neurological or cardiovascular disease.
• Person with a chronic respiratory disease, for example: asthma, COPD, interstitial lung disease, bronchial dilation, cystic fibrosis,
• Person with a history of exercise-induced bronchospasm.
• Person taking inhaled treatments (corticotherapy, bronchodilators, anticholinergics)
• Pregnant woman (declarative).

Trial design

Primary purpose: Basic Science

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

9 participants in 1 patient group

Interventionnal

Experimental group

Description:

Measure DEP, DEM25, DEM 50, DEM 75, FVC, Inspiratory capacity, SpO2, Respiratory rate before, during, or after the state of self-induced cognitive trance Evolution of the feeling of self-efficacy, assessed by questionnaire.

Treatment:

Diagnostic Test: spirometry